General Information of Drug (ID: DMJRK9D)

Drug Name
1313212-89-3
Synonyms Ethyl N-[(4-Aminobenzyl)carbamoyl]glycinate; ethyl 2-(3-(4-aminobenzyl)ureido)acetate; SCHEMBL2044119; CHEMBL3647424; BDBM139995; 1313212-89-3; US8901295, F428
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 251.28
Logarithm of the Partition Coefficient (xlogp) 0.5
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C12H17N3O3
IUPAC Name
ethyl 2-[(4-aminophenyl)methylcarbamoylamino]acetate
Canonical SMILES
CCOC(=O)CNC(=O)NCC1=CC=C(C=C1)N
InChI
InChI=1S/C12H17N3O3/c1-2-18-11(16)8-15-12(17)14-7-9-3-5-10(13)6-4-9/h3-6H,2,7-8,13H2,1H3,(H2,14,15,17)
InChIKey
UCMPTJMHPJQEED-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
53259809
TTD ID
D0M2OY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Rotamase D (PPID) TTNAFOU PPID_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Inhibitors of cyclophilins and uses thereof. US8901295.